The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the survival was ten percent five year survival with seven and three today with the same drug it's about 26 percent why has it increased because the supportive care measures are better we have better antibiotics we can give more platelets and red cell transfusions are easier to give we've learned to manage better that's it the supportive care is better but the backbone of treatment is the same seven and three
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.